FDA.reportPublic FDA data

Redemplo 25 MG per 0.5 ML Prefilled Syringe

RxCUI
2728184
RxNorm name
Redemplo 25 MG per 0.5 ML Prefilled Syringe
Display name
Redemplo 25 MG per 0.5 ML Prefilled Syringe
Full name
Redemplo 25 MG per 0.5 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
REDEMPLOPLOZASIRANArrowhead Pharmaceuticals, Inc.7fd37993-f85a-4af1-8bbe-133299f226ed2026-08-25Adverse reactionsExact identifier
rxcui: 2728184

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7fd37993-f85a-4af1-8bbe-133299f226edRedemplo 25 MG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML plozasiran 50 MG/ML Prefilled Syringe [Redemplo] [SBD] · Redemplo 25 MG per 0.5 ML Prefilled Syringe [SY] · Redemplo 50 MG/ML per 0.5 ML Prefilled Syringe [SY]43These highlights do not include all the information needed to use REDEMPLO ® safely and effectively. See full prescribing information for REDEMPLO. REDEMPLO (plozasiran) injection, for subcutaneous use Initial U.S. Approval: 202520251124